Chinese Journal of Hepatology 2007 Issue 1 Retrospective and perspectives in HBV drug-resistant variations

Retrospective and perspectives in HBV drug-resistant variations
HOU Jin-lin;SUN Jian;WANG Cheng

..............page:1-3

The rate of hepatitis B virus resistance to adefovir dipivoxil (ADV) and the evolution of hepatitis B virus in lamivudine-resistant chronic hepatitis B patients with ADV monotherapy
QIN Yan-li;ZHANG Ji-ming;HUANG Yu-xian;MAO Ri-cheng;YIN You-kuan;ZHANG Wan-qin;ZHANG Qing-bo;WU Xiang-hui;WENG Xin-hua

..............page:4-7

Significance of novel HBV expression vectors in selecting antiviral drugs in clinical therapy
LU Yin-ping;DONG Ji-hua;LIU Zhao;GUAN Shi-he;LU Meng-ji;YANG Dong-liang

..............page:8-12

Investigation of entecavir medication of chronic hepatitis B patients in the Chongqing area who failed lamivudine treatment
WANG Zhi-yi;ZHANG Da-zhi;SHI Xiao-feng;ZHOU Zhi;REN Hong

..............page:13-15

The relationships among HBV genotypes, HBV DNA levels and histopathological features in the livers of familial grouped hepatitis B patients in the Tianjin area
SHAO Feng-zhen;SHI Bo-an;LIU Wen-quan;CUI Li-an;SHANG Hong-ye;ZHANG Qin;ZHANG Jun-fu

..............page:16-18

Phenotypes and functions of dendritic cells derived from peripheral blood monocytes of chronic hepatitis B patients with different HBV DNA loads
CHEN Ming-quan;SHI Guang-feng;LU Qing;LI Qian;ZHANG Qiong-hua;QIN Gang;WENG Xin-hua

..............page:19-23

Study on the mechanism of HLA- Ⅰ -expressing regulation caused by the core region mutation of HBV adr subtype
WANG Jiu-ping;WANG Ping-zhong;LI Jun;PAN Lei;ZHANG Ying;LI Xin-hong;WANG Lin-xu;CHEN Wei-hong

..............page:24-27

Immune response to HSP70-HBcAg(18-27) complex in HBV transgenic mice
HU Huai-dong;HU Peng;CHEN Guo-lin;PENG Ming-li;CHEN Min;REN Hong

..............page:28-31

Mechanisms of human telomerase reverse transcriptase RNAi which increases hepatocellular carcinoma cell apoptosis induced by TRAIL
ZHANG Ru-gang;FANG Dian-chun;NING Xiao-yan;WANG Guo-an

..............page:32-36

Osteopontin promotes the malignant phenotypes of human hepatocellular carcinoma cell line SMMC-7721
CHEN Rong-xin;XUE Tong-chun;YE Sheng-long;SUN Rui-xia;ZHAO Yan;TANG Zhao-you

..............page:37-40

The role of apoptosis and the related genes in non-alcoholic steatohepatitis
NAN Yue-min;WU Wen-juan;YAO Xi-xian;WANG Lei

..............page:41-46

Analysis of the complications of liver biopsies using three different methods: report of 1557 cases
QIAN Lin-xue;WANG Bao-en

..............page:47-49

An oligonucletide microarray analysis of differential gene expressions of liver cells after warm ischemic injury
ZHANG Shao;HE Xiao-shun;ZHU Xiao-feng;WANG Dong-ping;MA Yi;JU Wei-qiang;WU Lin-wei;ZHANG Jing;HUANG Jie-fu

..............page:50-54

Mutation incidence of and resistant sites in HBV after longterm nucleoside analogs therapy
LIANG Xue-song;WAN Mo-bin

..............page:55-56

Drug resistance in the patients with chronic hepatitis B: prevention and treatment
ZHANG Da-zhi

..............page:57-58

Association of nonalcoholic fatty liver disease with serum adiponectin and insulin resistance
SHI Sheng-li;NIE Yu-qiang;LI Yu-yuan;ZHOU Yong-jian;MA Jin-xiang

..............page:58-59

The expression of macrophage migration-inhibitory factor in HBV-infection-related liver diseases
YU Xiao-hui;LIU Cong;WU Xiong-zhi;ZHANG Fang-xin;ZHAO Lian-san

..............page:60-61

Detection of serum concentration of tumor necrosis factor alpha, interleukin-10, and interleukin-15 and their clinical significance in patients with hepatic failure
ZHENG Yu;LU Ming-qin;LI Ji;DONG Pei-hong;YE Hao-hao;CHEN Yong-ping

..............page:62-63

The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease
CHEN Shao-hua;LI You-ming;YU Chao-hui;JIANG Ling-ling

..............page:64-65

Immunological characteristics of autoantibodies of autoimmune liver disease patients
ZHANG Li-fang;YAN You-gong;FU Li-ping;XU Juan

..............page:66-67

Relationship between ultrasound types of portosystemic shunts and hepatic encephalopathy in patients with portal hypertension
ZHANG Xin-li;CHEN Zhong

..............page:68-69

Clinical features of hepatitis B e antigen negative chronic severe hepatitis B patients
SUN Qing-feng;WANG Wen-bing;XU Dao-zhen;LI Yun-ru;DING Ji-guang

..............page:70-72

The effects of infused sertoli cells in liver transplants on the rejection of the transplants: an experimental study with rats
LIU Li-xin;GAO Ping;PENG Fang-xing;CHEN Yong-bing;YAN Lü-nan

..............page:72-73

Pentastomiasis of the liver: a case report
CHEN Li-an;HU Xi-qi

..............page:46

Autoimmune hepatitis and liver transplantation
CHU Zhi-qiang;SUN Li-ying

..............page:74-75

Advances in plasma proteome analysis in liver diseases
LIU Jie;WANG Ji-yao

..............page:76-77

Diagnosis, management and prevention of hepatitis B virus reactivation during anticancer therapy
GUI Hong-lian;XIE Qing

..............page:78-80